tiprankstipranks
Advertisement
Advertisement

HK:9877 Stock Latest News

Jenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
Company AnnouncementsJenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
6d ago
9877
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
PremiumCompany Announcements
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
14d ago
9877
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
PremiumCompany Announcements
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
1M ago
9877
Jenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
PremiumCompany Announcements
Jenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
2M ago
9877
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
PremiumCompany Announcements
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
2M ago
9877
Jenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
PremiumCompany AnnouncementsJenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
2M ago
9877
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
3M ago
9877
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
Premium
Company Announcements
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
3M ago
9877
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
PremiumCompany Announcements
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
4M ago
9877
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
PremiumCompany Announcements
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
4M ago
9877
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
PremiumCompany Announcements
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
5M ago
9877
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
PremiumCompany Announcements
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
5M ago
9877
Jenscare Scientific Cancels Book Closure Period for H Shares
PremiumCompany AnnouncementsJenscare Scientific Cancels Book Closure Period for H Shares
6M ago
9877
Jenscare Scientific Proposes Governance Restructuring
Premium
Company Announcements
Jenscare Scientific Proposes Governance Restructuring
6M ago
9877
Jenscare Scientific Announces 2025 Extraordinary General Meeting
Premium
Company Announcements
Jenscare Scientific Announces 2025 Extraordinary General Meeting
6M ago
9877
Jenscare Scientific Announces Book Closure for 2025 EGM
PremiumCompany Announcements
Jenscare Scientific Announces Book Closure for 2025 EGM
6M ago
9877
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
PremiumCompany Announcements
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
7M ago
9877
Jenscare Scientific Clarifies Safety Results in Recent Announcements
PremiumCompany Announcements
Jenscare Scientific Clarifies Safety Results in Recent Announcements
7M ago
9877
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
PremiumCompany Announcements
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
7M ago
9877
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
PremiumCompany AnnouncementsJenscare Scientific Unveils Promising Clinical Results at TCT 2025
7M ago
9877
Jenscare Scientific Approves Share Issuance at 2025 EGM
Premium
Company Announcements
Jenscare Scientific Approves Share Issuance at 2025 EGM
8M ago
9877
Jenscare’s LuX-Valve Plus Gains Approval for Greater Bay Area Clinical Use
Premium
Company Announcements
Jenscare’s LuX-Valve Plus Gains Approval for Greater Bay Area Clinical Use
8M ago
9877

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >